Gordian Untangle Complex Disease
41 employees on LinkedIn · 7 known investors
Gordian Biotechnology develops therapies aimed at treating age-related diseases to extend healthy lifespan. It operates in the biotechnology and longevity space.
Investors · 7
Competitors · 1
by search overlapCompanies competing with Gordian Untangle Complex Disease for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.6M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Gordian Untangle Complex Disease do?
- Gordian Biotechnology develops therapies aimed at treating age-related diseases to extend healthy lifespan. It operates in the biotechnology and longevity space.
- Who are Gordian Untangle Complex Disease's investors?
- Gordian Untangle Complex Disease's investors include age1, Fifty Years, Metaplanet, Prime Movers Lab, Streamlined Ventures, W ventures, 10x Founders.


